# Epileptic Hippocampus in Alzheimer's Disease

> **NCT05899764** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 25 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** Brivaracetam

## Key facts

- **NCT ID:** NCT05899764
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2029-06-01
- **Final completion:** 2029-06-01
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05899764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05899764, "Epileptic Hippocampus in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05899764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*